Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Altea gains US grant for pain relief patch:

This article was originally published in Clinica

Executive Summary

Altea Development has received a phase I grant from the US National Institutes of Health (NIH) to develop its skin patch for the delivery of opioid pain medications. The micropore opioid patch is intended initially to provide continuous opioid delivery throughout the day and subsequently for patient-controlled, on-demand delivery for treating more severe pain, says the Atlanta, Georgia company. The system may benefit in particular those patients for whom oral drugs are ineffective or in cases where injections and infusion pumps are impractical, the firm adds.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts